Windtree Therapeutics Inc
WINT
WINT was delisted on the 4th of May, 2017.
33 hedge funds and large institutions have $6.57M invested in Windtree Therapeutics Inc in 2016 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 3 closing their positions.
1,037% more call options, than puts
Call options by funds: $557K | Put options by funds: $49K
13% more capital invested
Capital invested by funds: $5.83M → $6.57M (+$743K)
3% less funds holding
Funds holding: 34 → 33 (-1)
13% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 8
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$27.2K |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
+$22.8K |
| 3 |
Renaissance Technologies
New York
|
+$18.1K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
+$13.9K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$6.49K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$285K |
| 2 |
Millennium Management
New York
|
-$102K |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$49.9K |
| 4 |
Walleye Trading
New York
|
-$9K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.95K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MPWT
26
MassMutual Private Wealth & Trust
Windsor,
Connecticut
| $39 | – | – | – |
|
|
27
Walleye Trading
New York
| – | -$9K | -5,200 | Closed |
|
|
AG
28
Advisor Group
Phoenix,
Arizona
| – | +$314 | +130 | New |
|
WINT Hedge Fund Activity: Q2 2016 in Review
33 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Windtree Therapeutics Inc (WINT) for Q2 2016, worth a combined $6.57M — up 13% from $5.83M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of WINT and 2 opened new positions — a net loss of 1 holder — while 8 trimmed existing stakes and 7 added.
The largest buyer was UBS Group, adding an estimated $27.2K. The largest seller was Sabby Management, cutting an estimated $285K.
- 33 institutional investors held Windtree Therapeutics Inc (WINT) as of Q2 2016, down from 34 in Q1 2016.
- Funds reported $6.57M of Windtree Therapeutics Inc stock for Q2 2016, up 13% quarter-over-quarter.
- 2 funds opened new Windtree Therapeutics Inc positions in Q2 2016 and 3 closed out, a net change of -1 holder.
- The largest Windtree Therapeutics Inc buyer in Q2 2016 was UBS Group, an estimated $27.2K added.
- The largest Windtree Therapeutics Inc seller in Q2 2016 was Sabby Management, an estimated $285K sold.
Based on aggregated 13F filings for Q2 2016.